Refugia and the evolutionary epidemiology of drug resistance

Biology Letters

Volumn 11, Issue 11, 2015, Pages

  Park, Andrew W ^a   Haven, James ^a   Kaplan, Ray ^a   Gandon, Sylvain ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTRE D ECOLOGIE FONCTIONNELLE ET EVOLUTIVE   (France)

Author keywords

Drug resistance; Mathematical model; Pathogen evolution; Refugia; Spatial structure

Indexed keywords

ANIMAL; DISEASE TREATMENT; DRUG RESISTANCE; EPIDEMIOLOGY; EVOLUTIONARY BIOLOGY; HOST-PATHOGEN INTERACTION; NUMERICAL MODEL; PATHOGEN; PUBLIC HEALTH; REFUGIUM; SPATIAL DISTRIBUTION;

ANIMALIA;

ANIMAL; BIOLOGICAL MODEL; DRUG RESISTANCE; EPIDEMIOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MOLECULAR EVOLUTION; REFUGIUM;

ANIMALS; DRUG RESISTANCE; EPIDEMIOLOGIC METHODS; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; REFUGIUM;

EID: 84983283867     PISSN: 17449561     EISSN: 1744957X     Source Type: Journal    
DOI: 10.1098/rsbl.2015.0783     Document Type: Article

References (20)

1. Sangster NC. 2001 Managing parasiticide resistance. Vet. Parasitol. 98, 89-109. (doi:10.1016/S0304-4017(01)00425-3)
2. Hall RJ, Gubbins S, Gilligan CA. 2004 Invasion of drug and pesticide resistance is determined by a trade-off between treatment efficacy and relative fitness. Bull. Math. Biol. 66, 825-840. (doi:10. 1016/j.bulm.2003.11.006)
3. Babiker HA, Hastings IM, Swedberg G. 2009 Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Expert Rev. Anti Infect. Ther. 7, 581-593. (doi:10.1586/eri.09.29)
4. Kotze AC et al. 2014 Recent advances in candidategene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions. Int. J. Parasitol. Drugs Drug Resist. 4, 164-184. (doi:10. 1016/j.ijpddr.2014.07.007)
5. Leathwick DM, Waghorn TS, Miller CM, Candy PM, Oliver A-MB. 2012 Managing anthelmintic resistance-use of a combination anthelmintic and leaving some lambs untreated to slow the development of resistance to ivermectin. Vet. Parasitol. 187, 285-294. (doi:10.1016/j.vetpar. 2011.12.021)
6. Wyk JA, Bath GF. 2002 The FAMACHA system for managing haemonchosis in sheep and goats by clinically identifying individual animals for treatment. Vet. Res. 33, 509-529. (doi:10.1051/vetres:2002036)
7. Webster JP, Molyneux DH, Hotez PJ, Fenwick A. 2014 The contribution of mass drug administration to global health: past, present and future. Phil. Trans. R. Soc. B 369, 20130434. (doi:10.1098/rstb. 2013.0434)
8. Bowman DD. 2012 Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States. Parasites Vectors 5, 138. (doi:10.1186/1756-3305-5-138)
9. Wang DM, Bowman DD, Brown H, Harrington LC, Kaufman PE, McKay T, Nelson CT, Sharp JL, Lund R. 2014 Factors influencing U.S. canine heartworm (Dirofilaria immitis) prevalence. Parasites Vectors 7, 264. (doi:10.1186/1756-3305-7-264).
10. Wyk JA. 2001 Refugia-overlooked as perhaps the most potent factor concerning the development of anthelmintic resistance. Onderstepoort J. Vet. Res. 68, 55-67.
11. Débarre F, Lenormand T, Gandon S. 2009 Evolutionary epidemiology of drug-resistance in space. PLoS Comput. Biol. 5, e1000337. (doi:10. 1371/journal.pcbi.1000337)
12. McClure NS, Day T. 2014 A theoretical examination of the relative importance of evolution management and drug development for managing resistance. Proc. R. Soc. B 281, 20141861. (doi:10. 1098/rspb.2014.1861)
13. Kaminsky R et al. 2008 A new class of anthelmintics effective against drug-resistant nematodes. Nature 452, 176-180. (doi:10.1038/nature06722)
14. Roberts JA, Kruger P, Paterson DL, Lipman J. 2008 Antibiotic resistance-what's dosing got to do with it? Crit. Care Med. 36, 2433-2440. (doi:10.1097/CCM.0b013e318180fe62)
15. Mishra PJ. 2012 The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins. Pharmacogenomics 13, 1321-1324. (doi:10.2217/pgs.12.121)
16. Hampton T. 2015 Designing drug combinations to prevent antibiotic resistance. J. Am. Med. Assoc. 313, 20. (doi:10.1001/jama.2014.17618)
17. Koella J, Antia R. 2003 Epidemiological models for the spread of anti-malarial resistance. Malar. J. 2, 3. (doi:10.1186/1475-2875-2-3)
18. Churcher TS, Basáñez M-G. 2008 Density dependence and the spread of anthelmintic resistance. Evolution 62, 528-537. (doi:10.1111/j. 1558-5646.2007.00290.x)
19. Tabashnik BE, Gassmann AJ, Crowder DW, Carriére Y. 2008 Insect resistance to Bt crops: evidence versus theory. Nat. Biotechnol. 26, 199-202. (doi:10.1038/nbt1382)
20. Day T, Gandon S. 2012 The evolutionary epidemiology of multilocus drug resistance. Evolution 66, 1582-1597. (doi:10.1111/j.1558-5646.2011.01533.x)